1.
Bioorg Med Chem Lett
; 19(15): 4484-7, 2009 Aug 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-19497737
RESUMEN
3-(1,1-Dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivatives as potential anti-HCV drugs targeting NS5B polymerase have been investigated. Their synthesis, HCV NS5B polymerase inhibition, and replicon activity are discussed.